FABP3 levels are elevated in toxic or drug-induced skeletal muscle injuries [43] in all forms of HF, including HF with preserved ejection fraction [44], in various cardiomyopathies [45], and in acute coronary syndrome [46], and it is a useful marker for ongoing myocardial damage [47]. Here, FABP3 is linked to acute coronary syndrome.